Publications by authors named "Mark B Carter"

Claim this Profile
C
Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.
Dominique R Perez, Yelena Smagley, Matthew Garcia, Mark B Carter, Annette Evangelisti

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Small-Molecule Nonfluorescent Inhibitors of Fluorogen-Fluorogen Activating Protein Binding Pair.
Yang Wu, Shaun R Stauffer, Robyn L Stanfield, Phillip H Tapia, Oleg Ursu, Mark B Carter

J Biomol Screen· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of isoxsuprine hydrochloride as a neuroprotectant in ischemic stroke through cell-based high-throughput screening.
Jeff W Hill, Jeffrey F Thompson, Mark B Carter, Bruce S Edwards, Larry A Sklar

PLoS One· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FRET detection of lymphocyte function-associated antigen-1 conformational extension.
Alexandre Chigaev, Yelena Smagley, Mark K Haynes, Oleg Ursu, Cristian G Bologa, Mark B Carter

Mol Biol Cell· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.
J Jacob Strouse, Irena Ivnitski-Steele, Anna Waller, Susan M Young, Dominique Perez, Mark B Carter

Anal Biochem· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A selective ATP-binding cassette subfamily G member 2 efflux inhibitor revealed via high-throughput flow cytometry.
J Jacob Strouse, Irena Ivnitski-Steele, Hadya M Khawaja, Dominique Perez, Jerec Ricci, Mark B Carter

J Biomol Screen· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster cytometry for high-capacity bioanalysis.
Bruce S Edwards, Jingshu Zhu, Jun Chen, Mark B Carter, David M Thal

Cytometry A· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a small molecule yeast TORC1 inhibitor with a multiplex screen based on flow cytometry.
Jun Chen, Susan M Young, Chris Allen, Andrew Seeber, Marie-Pierre Péli-Gulli, Mark B Carter

ACS Chem Biol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput flow cytometry based yeast two-hybrid array approach for large-scale analysis of protein-protein interactions.
Jun Chen, Mark B Carter, Bruce S Edwards, Hong Cai, Larry A Sklar

Cytometry A· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometry.
Ramona F Curpan, Peter C Simons, Dayong Zhai, Susan M Young, Mark B Carter

Assay Drug Dev Technol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.
Carlee E Ashley, Eric C Carnes, Genevieve K Phillips, Paul N Durfee, Mekensey D Buley, Mark B Carter

ACS Nano· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous in vitro molecular screening of protein-peptide interactions by flow cytometry, using six Bcl-2 family proteins as examples.
Peter C Simons, Susan M Young, Mark B Carter, Anna Waller, Dayong Zhai

Nat Protoc· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.
Carlee E Ashley, Eric C Carnes, Genevieve K Phillips, David Padilla, Paul N Durfee, Mark B Carter

Nat Mater· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening.
Larry A Sklar, Mark B Carter, Bruce S Edwards

Curr Opin Pharmacol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consequences of the loss of p53, RB1, and PTEN: relationship to gefitinib resistance in endometrial cancer.
Lina Albitar, Mark B Carter, Suzy Davies, Kimberly K Leslie

Gynecol Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis